Allegro
Monday, February 26, 2024
Plymouth
Regenerative Medicine
Reversing osteoarthritis.
Introducing an unprecedented category innovation in nanotechnology to fully restore the joint function in osteoarthritic patients, with impeccable results paving the way to completely change the landscape of osteoarthritis treatments.
Speakers
Country
Belgium
Website
https://www.allegro.bio
CEO/Top Company Official
Lucas Decuypere
Lead Product in Development
Xyletra, an injectable nanotechnology for the treatment of osteoarthritis.
Development Phase of Primary Product
Phase I
Number Of Unlicensed Products
1, Xyletra
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}